India's vaccination coverage to prevent rotavirus infection, a leading cause of severe diarrhoea in young children, was the lowest among the 15 countries which introduced it last year, a new report said Friday. It also pointed that India lost over 2.6 lakh children under five years from pneumonia and diarrhoea in 2016.
The report found health systems falling "woefully short" in ensuring that the most vulnerable children have access to prevention and treatment services in the 15 countries. including India, that account for 70 per cent of global pneumonia and diarrhoea deaths in children under five.
Despite significant reductions in disease in recent years because of improvements in access and use of health interventions, nearly half a million pneumonia and diarrhoea deaths still occurred in two countries - India and Nigeria, it said.
The number of deaths of children under five years due to pneumonia in 2016 was 1,58,176, while diarrhoea deaths was 1,02,813, the report said.
Released ahead of the 10th annual World Pneumonia Day on November 12, the 2018 Pneumonia and Diarrhea Progress Report by the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health describes progress in fighting these two diseases in 15 countries.
According to the report, the 15 nations in order with the highest number of pneumonia and diarrhoea child deaths are India, Nigeria, Pakistan, the Democratic Republic of Congo, Ethiopia, Chad, Angola, Somalia, Indonesia, Tanzania, China, Niger, Bangladesh, Uganda, and Cte d'Ivoire.
Elaborating about RotaC coverage, it said as of 2017, rotavirus vaccine had not been introduced in eight of the 15 focus countries Nigeria, DRC, Chad, Somalia, Indonesia, China, Bangladesh, and Uganda.
Of the seven countries where rotavirus vaccine has been introduced, the median coverage of complete rotavirus vaccine is 58 per cent.
"Among countries that had introduced the vaccine as of 2017, the lowest coverage levels were in Pakistan (12 per cent) and India (13 per cent), both of which had recently started phased national rollouts that had not yet reached all states or provinces," the report said.
Elaborating about the progress in India, home to more under-five pneumonia and diarrhoea deaths than any other country in 2016, has been "mixed", it said.
Increasing coverage of Haemophilus influenzae type b (Hib) vaccines as well as continued scale-up of rotavirus vaccines, first introduced in mid-2016, led to a bump in scoring for these interventions since last year's report.
"Introduced in 2017, the pneumococcal conjugate vaccine (PCV) has been included in only six states to-date. Further scale-up of the vaccine to all states should be considered," the report, which analysed government data, said.
It said India's scores for exclusive breast feeding declined as did coverage of ORS. "The proportion of children receiving important treatments remains dismally low, with barely 20 per cent receiving ORS for diarrhoeal disease," it said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
